UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 38

Sortiert nach

Loss of the preferential control over the striato-nigral direct pathway by striatal NMDA receptors in a rat model of Parkinson's disease

Analyst (London), 2015-06, Vol.14 (11), p.383-3839

2015

Link zum Volltext

Verfügbarkeit prüfen

Voltage-operated Ca2+ channels regulate dopamine release from somata of dopamine neurons in the substantia nigra pars compacta

Biochemical and biophysical research communications, 2008-09, Vol.373 (4), p.665-669

2008

Link zum Volltext

Verfügbarkeit prüfen

Neurturin Effects on Nigrostriatal Dopamine Release and Content: Comparison with GDNF

Neurochemical research, 2010-05, Vol.35 (5), p.727-734

2010

Link zum Volltext

Verfügbarkeit prüfen

Effects of noradrenergic lesions on MPTP/MPP+ kinetics and MPTP-induced nigrostriatal dopamine depletions

The Journal of pharmacology and experimental therapeutics, 1997-10, Vol.283 (1), p.100

1997

Link zum Volltext

Verfügbarkeit prüfen

Prenatal cocaine exposure decreases nigrostriatal dopamine release in vitro: Effects of age and sex

Synapse (New York, N.Y.), 2004-08, Vol.53 (2), p.74-89

2004

Link zum Volltext

Verfügbarkeit prüfen

L-DOPA-induced modulation of GABA and glutamate release in substantia nigra pars reticulata in a rodent model of Parkinson's disease

Synapse (New York, N.Y.), 2004-05, Vol.52 (2), p.163-165

2004

Link zum Volltext

Verfügbarkeit prüfen

Modulation of neurotransmitter release in the basal ganglia of the rat brain by dynorphin peptides

The Journal of pharmacology and experimental therapeutics, 1999-09, Vol.290 (3), p.1307

1999

Link zum Volltext

Verfügbarkeit prüfen

alpha2-Adrenoceptor-mediated modulation of the release of GABA and noradrenaline in the rat substantia nigra pars reticulata

Neuroscience letters, 2006-03, Vol.395 (2), p.138-142

2006

Link zum Volltext

Verfügbarkeit prüfen

Amphetamine-induced and spontaneous release of dopamine from A9 and A10 cell dendrites: an in vitro electrophysiological study in the mouse

Journal of neural transmission. General section, 1991, Vol.84 (3), p.183

1991

Link zum Volltext

Verfügbarkeit prüfen

Rosmarinic acid suppresses Alzheimer's disease development by reducing amyloid β aggregation by increasing monoamine secretion

Scientific reports, 2019-06, Vol.9 (1), p.8711-13, Article 8711

2019

Link zum Volltext

Verfügbarkeit prüfen

l -DOPA-induced dyskinesia in hemiparkinsonian rats is associated with up-regulation of adenylyl cyclase type V/VI and increased GABA release in the substantia nigra reticulata

Neurobiology of disease, 2011-01, Vol.41 (1), p.51-61

2011

Link zum Volltext

Verfügbarkeit prüfen

Phosphodiesterase 10A controls D1-mediated facilitation of GABA release from striato-nigral projections under normal and dopamine-depleted conditions

Neuropharmacology, 2014-01, Vol.76, p.127-136

2014

Link zum Volltext

Verfügbarkeit prüfen

P7C3 inhibits GSK3β activation to protect dopaminergic neurons against neurotoxin-induced cell death in vitro and in vivo

Cell death & disease, 2017-06, Vol.8 (6), p.e2858-e2858

2017

Link zum Volltext

Verfügbarkeit prüfen

Regional Difference in Susceptibility to Lipopolysaccharide-Induced Neurotoxicity in the Rat Brain: Role of Microglia

The Journal of neuroscience, 2000-08, Vol.20 (16), p.6309-6316

2000

Link zum Volltext

Verfügbarkeit prüfen

Neuroprotective activity of peripherally administered liver growth factor in a rat model of Parkinson's disease

PloS one, 2013-07, Vol.8 (7), p.e67771

2013

Link zum Volltext

Verfügbarkeit prüfen

Effect of electrical and chemical stimulation of the subthalamic nucleus on the release of striatal dopamine

Synapse (New York, N.Y.), 2010-12, Vol.64 (12), p.905-915

2010

Link zum Volltext

Verfügbarkeit prüfen

Is nicotine protective against Parkinson's disease? An experimental analysis

CNS & neurological disorders drug targets, 2012-11, Vol.11 (7), p.897

2012

Link zum Volltext

Verfügbarkeit prüfen

Fast-Scan Cyclic Voltammetry Analysis of Dynamic Serotonin Reponses to Acute Escitalopram

ACS chemical neuroscience, 2013-05, Vol.4 (5), p.715-720

2013

Link zum Volltext

Verfügbarkeit prüfen

Estrogen receptors and gonadal steroids in vulnerability and protection of dopamine neurons in a mouse model of Parkinson’s disease

Neuropharmacology, 2011-09, Vol.61 (4), p.583-591

2011

Link zum Volltext

Verfügbarkeit prüfen

Group III metabotropic glutamate-receptor-mediated modulation of excitatory transmission in rodent substantia nigra pars compacta dopamine neurons

The Journal of pharmacology and experimental therapeutics, 2005-06, Vol.313 (3), p.1296

2005

Link zum Volltext

Verfügbarkeit prüfen

Cystatin C prevents degeneration of rat nigral dopaminergic neurons: in vitro and in vivo studies

Neurobiology of disease, 2005-02, Vol.18 (1), p.152-165

2005

Link zum Volltext

Verfügbarkeit prüfen

FK506 Protects Against Various Immune Responses and Secondary Degeneration Following Cerebral Ischemia

Anatomical record (Hoboken, N.J. : 2007), 2009-12, Vol.292 (12), p.1993-2001

2009

Link zum Volltext

Verfügbarkeit prüfen

Increased glutamate-stimulated release of dopamine in substantia nigra of a rat model for attention-deficit/hyperactivity disorder—lack of effect of methylphenidate

Metabolic brain disease, 2009-12, Vol.24 (4), p.599-613

2009

Link zum Volltext

Verfügbarkeit prüfen

Levodopa/dopamine replacement strategies in Parkinson's disease-Future directions

Movement disorders, 2008, Vol.23 (S3), p.S613-S622

Olanow, C. Warren

2008

Link zum Volltext

Verfügbarkeit prüfen

GABA(B) receptors modulate depolarization-stimulated [³H]glutamate release in slices of the pars reticulata of the rat substantia nigra

European journal of pharmacology, 2010-12, Vol.649 (1-3), p.161-167

2010

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 38

Suche als RSS-Feed

Aktive Filter

ThemaBiological And Medical Sciences

ThemaSubstantia Nigra - Drug Effects

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(36)
Mit Volltextzugriff
(27)

Publikationsform

Artikel
(38)

Sprache

Englisch
(38)
Japanisch
(3)

Erscheinungsjahr

n.n

Thema

14 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Loss of the preferential control over the striato-nigral direct pathway by striatal NMDA receptors in a rat model of Parkinson's disease

Voltage-operated Ca2+ channels regulate dopamine release from somata of dopamine neurons in the substantia nigra pars compacta

Neurturin Effects on Nigrostriatal Dopamine Release and Content: Comparison with GDNF

Effects of noradrenergic lesions on MPTP/MPP+ kinetics and MPTP-induced nigrostriatal dopamine depletions

Prenatal cocaine exposure decreases nigrostriatal dopamine release in vitro: Effects of age and sex

L-DOPA-induced modulation of GABA and glutamate release in substantia nigra pars reticulata in a rodent model of Parkinson's disease

Modulation of neurotransmitter release in the basal ganglia of the rat brain by dynorphin peptides

alpha2-Adrenoceptor-mediated modulation of the release of GABA and noradrenaline in the rat substantia nigra pars reticulata

Amphetamine-induced and spontaneous release of dopamine from A9 and A10 cell dendrites: an in vitro electrophysiological study in the mouse

Rosmarinic acid suppresses Alzheimer's disease development by reducing amyloid β aggregation by increasing monoamine secretion

l -DOPA-induced dyskinesia in hemiparkinsonian rats is associated with up-regulation of adenylyl cyclase type V/VI and increased GABA release in the substantia nigra reticulata

Phosphodiesterase 10A controls D1-mediated facilitation of GABA release from striato-nigral projections under normal and dopamine-depleted conditions

P7C3 inhibits GSK3β activation to protect dopaminergic neurons against neurotoxin-induced cell death in vitro and in vivo

Regional Difference in Susceptibility to Lipopolysaccharide-Induced Neurotoxicity in the Rat Brain: Role of Microglia

Neuroprotective activity of peripherally administered liver growth factor in a rat model of Parkinson's disease

Effect of electrical and chemical stimulation of the subthalamic nucleus on the release of striatal dopamine

Is nicotine protective against Parkinson's disease? An experimental analysis

Fast-Scan Cyclic Voltammetry Analysis of Dynamic Serotonin Reponses to Acute Escitalopram

Estrogen receptors and gonadal steroids in vulnerability and protection of dopamine neurons in a mouse model of Parkinson’s disease

Group III metabotropic glutamate-receptor-mediated modulation of excitatory transmission in rodent substantia nigra pars compacta dopamine neurons

Cystatin C prevents degeneration of rat nigral dopaminergic neurons: in vitro and in vivo studies

FK506 Protects Against Various Immune Responses and Secondary Degeneration Following Cerebral Ischemia

Increased glutamate-stimulated release of dopamine in substantia nigra of a rat model for attention-deficit/hyperactivity disorder—lack of effect of methylphenidate

Levodopa/dopamine replacement strategies in Parkinson's disease-Future directions

GABA(B) receptors modulate depolarization-stimulated [³H]glutamate release in slices of the pars reticulata of the rat substantia nigra

Aktive Filter

Suchergebnisse filtern